Evaluating and accelerating treatment development:

Identifying, developing, assessing, and scaling up drug products

  • Playing a catalytic role in evaluating new and repurposed drugs for patients with COVID-19
  • Performing antiviral screening assays for repurposing pre-approved drugs for COVID-19

Drawing on our expertise in developing antimicrobial solutions:

  • Bringing together resources and expertise to develop and evaluate products with antiseptic properties against SARS-CoV-2
  • Identifying, researching, and testing for efficacy using antimicrobial & antiviral screening assays